DarioHealth Corp Research and Development Expense Trend

DarioHealth Corp -- USA Stock  

USD 1.56  0.10  6.85%

This module enables investors to look at DarioHealth Corp various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 2 M, Interest Expense of 2 M or Operating Expenses of 8.1 M, but also many exotic indicators such as Asset Turnover of 0.2659, Current Ratio of 2.58 or Free Cash Flow per Share of 0.63. This module is a perfect complement to use when analyzing DarioHealth Corp Valuation or Volatility. It can also complement various DarioHealth Corp Technical models. Additionally see analysis of DarioHealth Corp Correlation with competitors.
Showing smoothed Research and Development Expense of DarioHealth Corp with missing and latest data points interpolated. A component of Operating Expenses representing the aggregate costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service.
Research and Development Expense  10 Years Trend  
Slightly volatile
 Research and Development Expense 

DarioHealth Corp Research and Development Expense Over Time

2016-12-31  2,565,000 
2017-12-31  2,565,000 
2018-12-31  3,017,647 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  2,313,577
Geometric Mean  2,115,068
Coefficient Of Variation  47.86
Mean Deviation  874,798
Median  1,501,265
Standard Deviation  1,107,216
Range  3,410,735
R Value  0.58
R Squared  0.34
Significance  0.036581
Slope  165,700

Currently Trending

Sold over 70 shares of
a day ago ago
Traded for 37.94
Purchased over 40 shares of
a day ago ago
Traded for 61.5945
Sold over 200 shares of
a day ago ago
Traded for 11.15